Deutsche Bank’s Medicines Co MDCO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-44,804
| Closed | -$3.8M | – | 5176 |
|
|
2019
Q4 | $3.8M | Sell |
44,804
-688,173
| -94% | -$45.9M | ﹤0.01% | 1609 |
|
|
2019
Q3 | $36.6M | Buy |
732,977
+66,731
| +10% | +$2.66M | 0.03% | 570 |
|
|
2019
Q2 | $24.3M | Buy |
666,246
+378,126
| +131% | +$12.3M | 0.01% | 868 |
|
|
2019
Q1 | $8.05M | Sell |
288,120
-55,725
| -16% | -$1.31M | ﹤0.01% | 1522 |
|
|
2018
Q4 | $6.58M | Buy |
343,845
+114,862
| +50% | +$2.67M | ﹤0.01% | 1567 |
|
|
2018
Q3 | $6.85M | Sell |
228,983
-79,907
| -26% | -$3.01M | ﹤0.01% | 1946 |
|
|
2018
Q2 | $11.3M | Sell |
308,890
-22,433
| -7% | -$729K | 0.01% | 1637 |
|
|
2018
Q1 | $10.9M | Buy |
331,323
+145,293
| +78% | +$4.54M | 0.01% | 1546 |
|
|
2017
Q4 | $5.08M | Sell |
186,030
-187,481
| -50% | -$5.77M | ﹤0.01% | 2016 |
|
|
2017
Q3 | $13.8M | Sell |
373,511
-175,662
| -32% | -$6.48M | 0.01% | 1244 |
|
|
2017
Q2 | $20.9M | Buy |
549,173
+380,177
| +225% | +$16.9M | 0.01% | 920 |
|
|
2017
Q1 | $8.26M | Buy |
168,996
+52,964
| +46% | +$2.42M | 0.01% | 1381 |
|
|
2016
Q4 | $3.94M | Sell |
116,032
-123,903
| -52% | -$4.39M | ﹤0.01% | 1807 |
|
|
2016
Q3 | $9.05M | Sell |
239,935
-365,484
| -60% | -$13.8M | 0.01% | 1378 |
|
|
2016
Q2 | $20.4M | Sell |
605,419
-62,792
| -9% | -$2.21M | 0.01% | 907 |
|
|
2016
Q1 | $21.2M | Buy |
668,211
+162,401
| +32% | +$5.3M | 0.02% | 865 |
|
|
2015
Q4 | $18.9M | Sell |
505,810
-18,571
| -4% | -$702K | 0.01% | 944 |
|
|
2015
Q3 | $19.9M | Buy |
524,381
+11,105
| +2% | +$390K | 0.02% | 886 |
|
|
2015
Q2 | $14.7M | Buy |
513,276
+203,626
| +66% | +$5.67M | 0.01% | 1109 |
|
|
2015
Q1 | $8.67M | Sell |
309,650
-1,916
| -0.6% | -$53.8K | 0.01% | 1442 |
|
|
2014
Q4 | $8.62M | Buy |
311,566
+45,197
| +17% | +$1.12M | 0.01% | 1538 |
|
|
2014
Q3 | $5.94M | Buy |
266,369
+28,829
| +12% | +$732K | ﹤0.01% | 1696 |
|
|
2014
Q2 | $6.9M | Buy |
237,540
+537
| +0.2% | +$14.3K | ﹤0.01% | 1594 |
|
|
2014
Q1 | $6.73M | Buy |
237,003
+13,615
| +6% | +$451K | ﹤0.01% | 1603 |
|
|
2013
Q4 | $8.63M | Sell |
223,388
-71,043
| -24% | -$2.54M | 0.01% | 1430 |
|
|
2013
Q3 | $9.87M | Buy |
294,431
+12,600
| +4% | +$401K | 0.01% | 1338 |
|
|
2013
Q2 | $8.67M | Buy |
+281,831
| New | +$9.43M | 0.01% | 1317 |
|
Other funds holding MDCO
Deutsche Bank's MDCO Position: Q1 2020 in Review
Deutsche Bank sold out of Medicines Co (MDCO) in Q1 2020, closing a stake of 44,804 shares — an estimated $3.8M sold.
Deutsche Bank first reported a position in MDCO in Q2 2013 and held it in 27 quarters. The position peaked at $36.6M in Q3 2019. 1 fund tracked by Wall St. Rank holds MDCO as of Q1 2020.
- Deutsche Bank reported no remaining Medicines Co position as of Q1 2020 after selling out during the quarter.
- Deutsche Bank sold 44,804 Medicines Co shares in Q1 2020, an estimated $3.8M.
- Deutsche Bank first reported a position in Medicines Co in Q2 2013 and held it in 27 quarters.
- Deutsche Bank's Medicines Co position peaked at $36.6M in Q3 2019.
- 1 fund tracked by Wall St. Rank held Medicines Co as of Q1 2020.
Based on Deutsche Bank's 13F filing for Q1 2020, filed 14 May 2020.